1naresh
Array
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
1nareshArray
(
[urn:ac.highwire.org:guest:identity] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:identity
[type] => guest
[service-id] => ajnr-ac.highwire.org
[access-type] => Controlled
[privilege] => Array
(
[urn:ac.highwire.org:guest:privilege] => Array
(
[runtime-id] => urn:ac.highwire.org:guest:privilege
[type] => privilege-set
[privilege-set] => GUEST
)
)
[credentials] => Array
(
[method] => guest
)
)
)
Table 2: Summary of Hounsfield units by phase and lesion type using 2 categories—recurrence and benign (includes both normal and diseased thyroid)
Phase/Group No. Mean SD Min Max P Value Precontrast Benign thyroid 58 98.55 19.79 54 138 <.001 Recurrence 29 37.09 17.91 10.8 93 Arterial Benign thyroid 58 209.59 42.06 131 331 <.001 Recurrence 29 99.98 37.67 39.7 174 Venous Benign thyroid 58 176.38 36.47 96 263 <.001 Recurrence 29 90.61 31.69 28.2 156 Delayed Benign thyroid 58 158.19 31.19 94 238 <.001 Recurrence 29 87.83 28.6 24.2 155
Note:—Min indicates minimum; Max, maximum.